Key result
Statin therapy was associated with decreasing national cardiovascular mortality, averting an estimated 6.3 acute myocardial infarction deaths per 10,000 person-years.
Why the study?
Does statin therapy contribute to the decline in national cardiovascular mortality rates?
Observational
Does statin therapy contribute to the decline in national cardiovascular mortality rates?
Increased statin use at the population level was associated with a significant reduction in national cardiovascular mortality rates in The Netherlands from 1994 to 2010.
Answers are grounded in this paper and cite their sources.
Statin use was associated with CV mortality declines; leaves open causal contribution without individual-level data.
BACKGROUND: We assessed the contribution of statin use to the decline in cardiovascular mortality for The Netherlands over the period 1994-2010. METHODS: We combined aggregated mortality data from Statistics Netherlands with dispensing data from a representative drug dispensing database. We estimated mortality as if prevalence of statin use had remained at its observed 1994 levels throughout the period 1994-2010 for acute myocardial infarction, other ischemic heart disease, and cerebrovascular disease using Poisson models adjusted for various confounders. RESULTS: We estimated that keeping prevalence of statin use at observed 1994 levels would have resulted in 6.3 (95% confidence interval [CI] = 4.9, 7.8), 1.6 (95% CI = 0.8, 2.6), and 3.4 (95% CI = 2.2, 4.6) more acute myocardial infarction, ischemic heart disease, and cerebrovascular deaths per 10,000 person-years, respectively. CONCLUSION: The findings indicate that statin therapy was associated with decreasing national cardiovascular mortality rates in the period 1994 to 2010.
No takes yet. Share an insight, caveat, or question.
Bijlsma et al. (2015) conducted an observational in Cardiovascular mortality. Statin use vs. Prevalence of statin use at observed 1994 levels was evaluated on Acute myocardial infarction deaths per 10,000 person-years (6.3 more deaths per 10,000 person-years, 95% CI 4.9, 7.8). Statin therapy was associated with decreasing national cardiovascular mortality, averting an estimated 6.3 acute myocardial infarction deaths per 10,000 person-years.
Synapse has enriched 10 related papers. Consider them for comparative context: